Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapted Immunosuppression in Kidney Transplantation (CD4-01)
NCT00895206Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2009
- Primary completion
- Aug 2016
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil, tacrolimus in kidney transplantation, sponsored by Ghent University Hospital. Started May 2009; status: completed.
02
Drugs
mycophenolate mofetiltacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00895206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895206.